Healthcare ❯ Healthcare Policy

Drug Pricing

340B Program Drug Cost Transparency Pharmaceutical Industry Medicare Negotiations Mark Cuban Cost Plus Drugs Co.

Senators Move Toward 340B Overhaul After GAO Flags Oversight Gaps

GAO testimony that oversight lags is steering senators toward transparency measures, tougher audits, plus tighter rules on off‑site expansions.